Teladoc Health, Inc. (TDOC)
USD 9.46
(-6.06%)
USD 9.46
(-6.06%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.09 Billion USD | 8.61% |
| 2022 | 1.89 Billion USD | 16.58% |
| 2021 | 1.62 Billion USD | 44.6% |
| 2020 | 1.12 Billion USD | 153.31% |
| 2019 | 442.66 Million USD | 24.65% |
| 2018 | 355.13 Million USD | 51.86% |
| 2017 | 233.85 Million USD | 59.2% |
| 2016 | 146.89 Million USD | 31.0% |
| 2015 | 112.12 Million USD | 130.01% |
| 2014 | 48.74 Million USD | 125.8% |
| 2013 | 21.58 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 407.01 Million USD | -5.52% |
| 2024 Q1 | 430.77 Million USD | 80.98% |
| 2024 Q3 | 505.16 Million USD | 24.12% |
| 2023 Q1 | 502.19 Million USD | 4.36% |
| 2023 Q3 | 386.15 Million USD | -25.87% |
| 2023 Q4 | 238.03 Million USD | -38.36% |
| 2023 FY | 2.05 Billion USD | 8.61% |
| 2023 Q2 | 520.9 Million USD | 3.73% |
| 2022 FY | 1.89 Billion USD | 16.58% |
| 2022 Q4 | 481.21 Million USD | -2.97% |
| 2022 Q1 | 443.19 Million USD | 6.51% |
| 2022 Q2 | 473.56 Million USD | 6.85% |
| 2022 Q3 | 495.91 Million USD | 4.72% |
| 2021 FY | 1.62 Billion USD | 44.6% |
| 2021 Q4 | 416.12 Million USD | 1.78% |
| 2021 Q3 | 408.85 Million USD | -0.38% |
| 2021 Q1 | 386.07 Million USD | -41.62% |
| 2021 Q2 | 410.39 Million USD | 6.3% |
| 2020 Q4 | 661.33 Million USD | 270.67% |
| 2020 Q3 | 178.41 Million USD | 14.52% |
| 2020 FY | 1.12 Billion USD | 153.31% |
| 2020 Q1 | 125.76 Million USD | 10.08% |
| 2020 Q2 | 155.8 Million USD | 23.88% |
| 2019 Q1 | 105.77 Million USD | 6.71% |
| 2019 Q3 | 113.11 Million USD | 3.28% |
| 2019 Q2 | 109.52 Million USD | 3.55% |
| 2019 Q4 | 114.24 Million USD | 1.0% |
| 2019 FY | 442.66 Million USD | 24.65% |
| 2018 Q3 | 92.41 Million USD | 10.95% |
| 2018 Q1 | 80.31 Million USD | 5.08% |
| 2018 FY | 355.13 Million USD | 51.86% |
| 2018 Q4 | 99.11 Million USD | 7.25% |
| 2018 Q2 | 83.29 Million USD | 3.71% |
| 2017 Q4 | 76.42 Million USD | 17.72% |
| 2017 FY | 233.85 Million USD | 59.2% |
| 2017 Q3 | 64.92 Million USD | 38.3% |
| 2017 Q2 | 46.94 Million USD | 3.04% |
| 2017 Q1 | 45.56 Million USD | 12.21% |
| 2016 Q2 | 34.05 Million USD | 1.19% |
| 2016 Q1 | 33.66 Million USD | 10.34% |
| 2016 Q4 | 40.6 Million USD | 3.24% |
| 2016 FY | 146.89 Million USD | 31.0% |
| 2016 Q3 | 39.33 Million USD | 15.48% |
| 2015 Q1 | 23.8 Million USD | 54.5% |
| 2015 FY | 112.12 Million USD | 130.01% |
| 2015 Q4 | 30.5 Million USD | 8.64% |
| 2015 Q3 | 28.08 Million USD | -5.58% |
| 2015 Q2 | 29.74 Million USD | 24.96% |
| 2014 Q1 | 9.61 Million USD | 0.0% |
| 2014 Q3 | 12.61 Million USD | 13.41% |
| 2014 Q4 | 15.4 Million USD | 22.16% |
| 2014 Q2 | 11.12 Million USD | 15.68% |
| 2014 FY | 48.74 Million USD | 125.8% |
| 2013 FY | 21.58 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Well Corporation | 786.9 Million USD | -165.717% |
| Doximity, Inc. | 260.87 Million USD | -701.509% |
| Evolent Health, Inc. | 531.68 Million USD | -293.269% |
| MultiPlan Corporation | 564.07 Million USD | -270.685% |
| Phreesia, Inc. | 369.84 Million USD | -465.361% |
| Veeva Systems Inc. | 1.25 Billion USD | -66.337% |